miRagen Reports Second Quarter 2019 Results; Regains Global Rights to MRG-110 and Announces Corporate Restructuring

NEXT STORY
CytomX Therapeutics Announces Second Quarter 2019 Financial Results and Provides Business Update
PREV STORY
Verrica Pharmaceuticals Reports Second Quarter 2019 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Calithera to Present at the 2021 Jefferies London Healthcare Conference

author_avatar
NASDAQ Market News

ZIOPHARM Oncology Announces Positive Updated Results of Ad-RTS-hIL-12 + Veledimex in Recurrent Glioblastoma at the 2017 ASCO Annual Meeting

Median Overall Survival in Expanded 20 mg Cohort Maintained at 12.5 Months and Continues ...

author_avatar
NASDAQ Market News

Novartis erzielt 2019 ein starkes Umsatzwachstum, Margen-steigerungen und bahnbrechende Innovationen mit der Markt¬einführung fünf neuer Wirkstoffe

author_avatar
NASDAQ Market News